Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Wiedemann

Showing results (1-10 of 320) with videos related to

Pageof 32
Sort By:
Long Range Planning|September 8, 1983
PINCO: personal information and confidentiality controlsP Wiedemann
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|October 1, 1993
[What is the etiology of diabetic retinopathy?]P Wiedemann
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1989
[Drug treatment of proliferative vitreoretinopathy]P Wiedemann
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 24, 1999
1998 Jules Gonin lecture of the Retina Research Foundation. Drug treatment of ocular neovascularization and proliferationP Wiedemann
Survey of Ophthalmology|March 1, 1992
Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degenerationP Wiedemann
The Journal of Laboratory and Clinical Medicine|March 1, 1996
Surfactant and acquired lung diseasesH P Wiedemann
ACP Journal Club|January 9, 2004
Noninvasive ventilation was cost-effective for reducing in-hospital mortality in COPDHerbert P Wiedemann
ZFA. Zeitschrift Fur Allgemeinmedizin|May 31, 1980
[Environmental protection. Only a new task for the public health service?]H P Wiedemann
ACP Journal Club|May 3, 2003
Activated protein C was cost-effective for prolonging survival in a subgroup of patients with severe sepsisHerbert P Wiedemann
ACP Journal Club|March 5, 2002
Review: mucolytic drugs reduce exacerbations, illness days, and antibiotic use in chronic bronchitis and COPDHerbert P Wiedemann
Pageof 32

Showing results (1-10 of 320) with videos related to

Sort By:
Pageof 32
Long Range Planning|September 8, 1983
PINCO: personal information and confidentiality controlsP Wiedemann
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|October 1, 1993
[What is the etiology of diabetic retinopathy?]P Wiedemann
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1989
[Drug treatment of proliferative vitreoretinopathy]P Wiedemann
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 24, 1999
1998 Jules Gonin lecture of the Retina Research Foundation. Drug treatment of ocular neovascularization and proliferationP Wiedemann
Survey of Ophthalmology|March 1, 1992
Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degenerationP Wiedemann
The Journal of Laboratory and Clinical Medicine|March 1, 1996
Surfactant and acquired lung diseasesH P Wiedemann
ACP Journal Club|January 9, 2004
Noninvasive ventilation was cost-effective for reducing in-hospital mortality in COPDHerbert P Wiedemann
ZFA. Zeitschrift Fur Allgemeinmedizin|May 31, 1980
[Environmental protection. Only a new task for the public health service?]H P Wiedemann
ACP Journal Club|May 3, 2003
Activated protein C was cost-effective for prolonging survival in a subgroup of patients with severe sepsisHerbert P Wiedemann
ACP Journal Club|March 5, 2002
Review: mucolytic drugs reduce exacerbations, illness days, and antibiotic use in chronic bronchitis and COPDHerbert P Wiedemann
Pageof 32